Drug-induced urticaria

Expert Opinion on Drug Safety

Volumn 3, Issue 5, 2004, Pages 471-484

  Tan, Eunice K H ^a   Grattan, Clive E H ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Allergy; Angio oedema; Drug reaction; Pseudoallergy; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANALGESIC AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FLURBIPROFEN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN DERIVATIVE; ROFECOXIB; SEROTONIN UPTAKE INHIBITOR; TICLOPIDINE; UNINDEXED DRUG; VACCINE;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG SELECTIVITY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; ERYTHEMA; FOOD DRUG INTERACTION; HUMAN; LOW DRUG DOSE; PATHOGENESIS; PROSPECTIVE STUDY; RELIABILITY; RESPIRATORY TRACT DISEASE; REVIEW; SERUM SICKNESS; SKIN ALLERGY; SKIN EDEMA; SKIN MANIFESTATION; SUBCUTANEOUS TISSUE; SUBMUCOSA; THROMBOCYTOPENIC PURPURA; UNITED KINGDOM; URTICARIA; VASCULITIS;

ANALGESICS; ANGIONEUROTIC EDEMA; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGEN-ANTIBODY COMPLEX; BRADYKININ; COMPLEMENT ACTIVATION; CROSS REACTIONS; CYCLOOXYGENASE INHIBITORS; DISEASE SUSCEPTIBILITY; DRUG ERUPTIONS; FOOD HYPERSENSITIVITY; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; URTICARIA; VACCINES;

EID: 4544261243     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.5.471     Document Type: Review

References (100)

1. IGBY M: Rates of cutaneous reactions to drugs. Arch. Dermatol. (2001) 137:765-770.
2. ETTIS E, MARCANDREA M, MAGGIO GD, FERRANNINI A, TURSI A: Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients. Immunopharmacol. Immunotoxicol. (2001) 23:585-595.
3. GRATTAN CE: The urticaria spectrum: recognition of clinical patterns can help management. Clin. Exp. Dermatol. (2004) 29:217-221.
4. ZUBERBIER T, GREAVES MW, JUHLIN L et al.: Definition, classification and routine diagnosis of urticaria: a consensus report. J. Investig. Dermatol. Symp. Proc. (2001) 6:123-127.
5. GRATTAN CE: Autoimmune urticaria. Immunol. Allergy Clin. North Am. (2004) 24:163-182.
6. ZUBERBIER T, IFFLÄNDER J, SEMMLER C, HENZ BM: Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm. Venereol. (1996) 76:295-237.
7. MORTUREUX P, LÉAUTÉ-LABÈRZE C, LEGRAIN-LIFERMANN V, LAMIREAU T, SARLANGUE J, TAÏEB A: Acute urticaria in infancy and early childhood. A prospective study. Arch. Dermatol. (1998) 134:319-323.
8. MOORE-ROBINSON M, WARIN RP: Effect of salicylates in urticaria. Br. Med. J. (1967) 4:262-264.
9. CHAMPION RH, ROBERTS SO, CARPENTER RG, ROGER JH: Urticaria and angio-oedema. A review of 554 patients. Br. J. Dermatol. (1969) 81:588-597.
10. JAMES J, WARIN RP: Chronic urticaria: the effect of aspirin. Br. J. Dermatol. (1970) 82:204-205.
11. DOEGLAS HM: Reactions to aspirin and food additives in patients with chronic urticaria, including the physical urticarias. Br. J. Dermatol. (1975) 93:135-144.
12. STEVENSON DD: Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J. Allergy Clin. Immunol. (1984) 74:617-622.
13. NETTIS E, PANNOFINO A, D'APRILE C, FERRANNINI A, TURSI A: Clinical and aetiological aspects in urticaria and angio-oedema. Br. J. Dermatol. (2003) 148:501-506.
14. GRATTAN CE: Aspirin sensitivity and urticaria. Clin. Exp. Dermatol. (2003) 28:123-127.
15. SETTIPANE RA, CONSTANTINE HP, SETTIPANE GA: Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review. Allergy (1980) 35:149-154.
16. NO AUTHORS LISTED: Cutaneous reactions to analgesics-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologica. Dermatology (1993) 186:164-169.
17. SETTIPANE GA, PUDUPAKKAM RK: Aspirin intolerance. III. Subtypes, familial occurrence and cross reactivity with tartrazine. J. Allergy Clin. Immunol. (1975) 56:215-221.
18. COUSIN F, PHILIPS K, FAVIER B, BIENVENU J, NICHOLAS JF: Drug-induced urticaria. Eur. J. Dermatol. (2001) 11:181-187.
19. JUHLIN L: Recurrent urticaria: clinical investigation of 330 patients. Br. J. Dermatol. (1981) 104:369-381.
20. CHAN CL, JONES RL, LAU HY: Characterisation of the prostanoid receptors mediating inhibition of histamine release from anti-IgE-activated rat peritoneal mast cells. Br. J. Pharmacol. (2000) 129:589-597.
21. CASALE TB, BOWMAN S, KALINER M: Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J. Allergy Clin. Immunol. (1984) 73:775-781.
22. COHEN RW, ROSENSTREICH DL: Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J. Allergy Clin. Immunol. (1986) 77:802-807.
23. ELLIS HV III, JOHNSON AR, MORAN NC: Selective release of histamine from rat mast cells by several drugs. J. Pharmacol. Exp. Ther. (1970) 175:627-631.
24. HOWES LG, TRAN D: Can angiotensin receptor antagonists be used safety in patients with previous ACE inhibitor-induced angioedema? Drug Saf. (2002) 25:73-76.
25. NUSSBERGER J, CUGNO M, AMSTUTZ C, CICARDI M, PELLACANI A, AGOSTONI A: Plasma bradykinin in angio-oedema. Lancet (1998) 351:1693-1697.
26. SABROE RA, KOBZA BLACK A: Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br. J. Dermatol. (1997) 136:153-158.
27. ZUBERBIER T, HENZ BM: Diagnosis of urticaria. In: Urticaria-Clinical Diagnostic and Therapeutic Aspects. Henz BM, Zuberbier T, Grabbe J, Monroe E (Eds), Springer, Berlin (1998):139-159.
28. HENZ BM: The spectrum of urticaria. In: Urticaria-Clinical Diagnostic and Therapeutic Aspects. Henz BM, Zuberbier T, Grabbe J, Monroe E (Eds), Springer, Berlin (1998):1-17.
29. WARIN RP: The effect of aspirin in chronic urticaria. Br. J. Dermatol. (1960) 72:350-351.
30. ELLIS MH: Successful treatment of chronic urticaria with leukotriene antagonists. J. Allergy Clin. Immunol. (1998) 102:876-877.
31. ASERO R: Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann. Allergy Asthma Immunol. (2000) 85:156-157.
32. PACOR ML, DI LORENZO G, CORROCHER R: Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and ceitrizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin. Exp. Allergy (2001) 31:1607-1614.
33. PÉREZ C, SÁNCHEZ-BORGES M, CAPRILES E: Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J. Allergy Clin. Immunol. (2001) 108:1060-1061.
34. ERBAGCI ZM: The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J. Allergy Clin. Immunol. (2002) 110:484-488.
35. ZEMBOWICZ A, MASTALERZ L, SETKOWICZ M, RADZISZEWSKI W, SZCZEKLIK A: Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch. Dermatol. (2003) 139:1577-1582.
36. SWAIN AR, DUTTON AP, TRUSWELL AS: Salicylates in foods. J. Am. Diet. Assoc. (1985) 85:950-960.
37. MICHAELSSON G, JUHLIN L: Urticaria induced by preservatives and dye additives in foods and drugs. Br. J. Dermatol. (1973) 88:525-532.
38. ZUBERBIER T, CHANTRAINE-HESS S, HARTMANN K, CZARNETSKI BM: Pseudoallergen-free diet in the treatment of chronic urticaria. Acta Derm. Venereol. (1995) 75:484-487.
39. ROS AM, JUHLIN L, MICHAËLSSON G: A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Br. J. Dermatol. (1976) 95:19-24.
40. WILLIAMS WR, PAWLOWICZ A, DAVIES BH: Aspirin-like effects of selected food additives and industrial sensitizing agents. Clin. Exp. Allergy (1989) 19:533-537.
41. SCHWARZ N, HAM PONG A: Acetaminophen anaphylaxis with aspirin and sodium salicylate sensitivity: a case report. Ann. Allergy Asthma Immunol. (1996) 77:473-474.
42. GRZELEWSKA-RZYMOWSKA I, SZMIDT M, ROZNIECKI J: Urticaria/angioedema-type sensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Diagnostic value of anamesis and challenge test with acetylsalicylic acid. J. Investig. Allergol. Clin. Immunol. (1992) 2:191-195.
43. BLANCA M, PEREZ E, GARCIA JJ et al.: Angioedema and IgE antibodies to aspirin: a case report. Ann. Allergy (1989) 62:295-297.
44. KUBOTA Y, IMAYAMA S, TOSHITANI A et al.: Sulfidoleukotriene release test (CAST) in hypersensitivity to nonsteroidal anti-inflammatory drugs. Int. Arch. Allergy Immunol. (1997) 114:361-366.
45. MAY A, WEBER A, GALL H, KAUFMANN R, ZOLLNER TM: Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin. Exp. Allergy (1999) 29:1402-1411.
46. STEVENSON DD, SIMON RA: Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Allergy: Principles and Practice (4th edn). Middleton E, Reed CE, Ellis EF et al. (Eds), Mosby (1993):1747-1765.
47. SZCZEKLIK A, GRYGLEWSKI RJ, CZERNIAWSKA-MYSIK G: Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br. Med. J. (1975) 1:67-69.
48. ASERO R: Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.Ann. Allergy Asthma Immunol. (1999) 82:554-558.
49. ASERO R: Multiple sensitivity to NSAID. Allergy (2000) 55:893-894.
50. ASERO R, TEDESCHI A, LORINI M: Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann. Allergy Asthma Immunol. (2002) 88:468-472.
51. STEVENSON DD, SANCHEZ-BORGES M, SZCZEKLIK A: Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol. (2001) 87:177-180.
52. ASERO R, TEDESCHI A, LORINI M, CARALDIRONI G, BAROCCI F: Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors. Int. Arch. Allergy Immunol. (2003) 131:195-200.
53. GRATTAN CE, WALLINGTON TB, WARIN RP et al.: A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br. J. Dermatol. (1986) 114:583-590.
54. FITZGERALD GA, PATRONO C: The coxibs, selective inhibitors of cyclooxygenase-2. N. Engl. J. Med. (2001) 345:433-442.
55. FISCHER TC, WORM M, GRONEBERG DA: Clopidogrel-associated angioedema. Am. J. Med. (2003) 114:77-78.
56. CHASSANY O, NARBOUX S, THOMAS L, COSSON S, CAULIN C: Quincke's edema during ticlopidine treatment. Presse Med. (1999) 28:18.
57. YOSIPOVITCH G, RECHAVIA E, FEINMESSER M, DAVID M: Adverse cutaneous reactions to ticlopidine in patients with coronary stents. J. Am. Acad. Dermatol. (1999) 41:473-476.
58. HASS WK, EASTON JD, ADMAS HP et al.: A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N. Engl. J. Med. (1989) 321:501-507.
59. WEINMANN P, MORETTI JL, LEYNADIER F: Anaphylaxis-like reaction induced by dipyridamole during myocardial scintigraphy. Am. J. Med. (1994) 97:488.
60. KOZEL MM, MEKKES JR, BOSSUYT PM, BOS JD: Natural course of physical and chronic urticaria and angioedema in 220 patients. J. Am. Acad. Dermatol. (2001) 45:387-391.
61. HUMPHREYS F, HUNTER JA: The characteristics of urticaria in 390 patients. Br. J. Dermatol. (1998) 138:635-638.
62. JUHLIN L: Recurrent urticaria: clinical investigation of 330 patients. Br. J. Dermatol. (1981) 104:369-381.
63. ORMEROD AD, REID TM, MAIN RA: Penicillin in milk - its importance in urticaria. Clin. Allergy (1987) 17:229-234.
64. MCINTOSH LJ: The incidence of antibodies in herd and retail milks in Scotland. J. Assoc. Publ. Anal. (1986) 24:81-90.
65. PETZ LD: Immunologic cross reactivity between penicillin and cephalosporins: a review. J. Infect. Dis. (1978) 137:S74-S79.
66. THOBURN R, JOHNSON JE III, CLUFF LE: Studies on the epidemiology of adverse reactions IV. The relationship of cephalothin and penicillin allergy. JAMA (1968) 198:111-114.
67. WEISS ME, ADKINSON NF: Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin. Allergy (1988) 18:515-540.
68. LIN RY: A perspective on penicillin allergy. Arch. Intern. Med. (1992) 152:930-937.
69. SHEPHERD GM: Allergy to β-lactam antibiotics. Immunol. Allergy Clin. North Am. (1991) 11:611-633.
70. SAXON A, HASSNER A, SWABB EA, WHEELER B, ADKINSON NF Jr: Lack of cross-reactivity between aztreonam, a monbactam antibiotic, and penicillin in penicillin-allergic subjects. J. Infect. Dis. (1984) 149:16-22.
71. ADKINSON NF Jr: Immunogenicity and cross-allergenicity of aztreonam. Am. J. Med. (1990) 88:S12-S15.
72. SAXON A, ADELMAN CD, PATEL A, HADJU R, CALANDRA GB: Imipenem cross-reactivity with penicillin in humans. J. Allergy Clin. Immunol. (1988) 82:213-217.
73. FAYS S, TRECHOT P, SCHMUTZ JL, CUNY JF, TRUCHETET F, BARBAUD A: Bupropion and generalized acute urticaria: eight cases. Br. J. Dermatol. (2003) 148:177-178.
74. LOO WJ, ALEXANDROFF A, FLANAGAN N: Bupropion and generalized acute urticaria: a further case. Br. J. Dermatol. (2003) 149:660.
75. CHIAVERINI C, BALDIN B, CHICHMANIAN RM, ORTONNE JP, LACOUR JP: Bupropion (Zyban) induced urticaria: 2 cases. Ann. Dermatol. Venereol. (2003) 130:208-209.
76. SPIGSET O: Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf. (1999) 20:277-287.
77. LEZNOFF A, BINKLEY KE, JOFFEE RT, LEVITT A, RICHTER MA: Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients. J. Clin. Psychopharmacol. (1992) 12:355-357.
78. MITHANI H, HURWITZ TA: Paroxetine-induced angioedema and tongue swelling. J. Clin. Psychiatry (1996) 57:486.
79. INMAN WH, RAWSON NS, WILTON LV et al.: Postmarketing surveillance of enalapril I: results of prescription-event monitoring. Br. Med. J. (1988) 297:826-829.
80. VLEEMING W, VAN AMSTERDAM JG, STRICKER C et al.: ACE inhibitor-induced angio-oedema. Incidence, prevention and management. Drug Saf. (1998) 18:171-188.
81. SLATER EE, MERRILL DD, GUESS HA et al.: Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA (1988) 260:967-970.
82. BURKHART GA, BROWN NJ, GRIFFIN MR et al.: Angiotensin converting enzyme inhibitor associated with angioedema: higher risk in blacks than in whites. Pharmacoepidemiol. Drug Saf. (1996) 5:149-154.
83. BROWN NH, RAT WA, SNOWDEN M et al.: Black Americans have an increased rate of angiotensin converting enzyme inhibitor associated angioedema. Clin. Pharmacol. Ther. (1996) 60:8-13.
84. KARAMFILOV T, WILMER A, HIPLER UC, WOLLINA U: Cetirizine-induced urticarial reaction. Br. J. Dermatol. (1999) 140:979-980.
85. 1-antihistamines. Allergy (2000) 55:679-680.
86. CALISTA D, SCHIANCHI S, MORRI M: Urticaria induced by cetirizine. Br. J. Dermatol. (2001) 144:196.
87. SCHROTER S, DAMVELD B, MARSCH WC: Urticarial intolerance reaction to cetirizine. Clin. Exp. Dermatol. (2002) 27:185-187.
88. TELLA R, GAIG P, BARTRA J, GARCIA-ORTEGA P: Urticaria to cetirizine. J. Investig. Allergol. Clin. Immunol. (2002) 12:136-137.
89. BARRANCO P, LOPEZ-SERRANO MC, MORENO-ANCILLO A: Anaphylactic reaction due to diphenhydramine. Allergy (1998) 53:814.
90. DELAUNOIS L: Hypersensitivity to cimetidine. N. Engl. J. Med. (1979) 300:1216.
91. BRANDRUP F: Urticaria caused by cimetidine therapy. Ugeskr. Laeger (1981) 143:1715-1716.
92. SANDHU BS, REQUENA R: Hypersensitivity to cimetidine. Ann. Intern. Med. (1982) 97:138.
93. PICARDO M, SANTUCCI B: Urticaria from ranitidine. Contact Dermatitis (1983) 9:327.
94. WHALEN JP: Hypersensitivity to cimetidine. J. Clin. Pharmacol. (1985) 25:610.
95. SANCHO CALABUIG A, PALOP LARREA V, LOPEZ GONZALEZ E, MARTINEZ-MIR I: Ranitidine and a rare adverse reaction: urticaria. Aten. Primaria (1997) 20:396-397.
96. QUIRALTE J, SÁENZ DE SAN PEDRO B, JOSÉ FERNANDO FLORIDO J: Safety of selective cyclooxygenase-2 inhibitor refecoxib in patients with NSAID-induced cutaneous reactions. Ann. Allergy Asthma Immunol. (2002) 89:63-66.
97. PACOR ML, DI LORENZO G, BLASI D, BARBAGALLO M, CORROCHER R: Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs. Clin. Exp. Allergy (2002) 32:397-400.
98. PERRONE MR, ARTESANI MC, VIOLA M et al.: Tolerability of rofecoxib in patients with adverse reactions to nonsteroidal anti-inflammatory drugs: a study of 216 patients and literature review. Int. Arch. Allergy Immunol. (2003) 132:82-86.
99. SÁNCHEZ-BORGES M, CAPRILE-HULETT A, CABALLERO-FONSECA F, PEREZ CR: Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. Ann. Allergy Asthma Immunol. (2001) 87:201-204.
100. ASERO R: Tolerability of rofecoxib. Allergy (2001) 56:916-917.